Skip to main content

How to Manage Osteolytic Lesions

  • Chapter
  • First Online:
  • 794 Accesses

Part of the book series: European Instructional Lectures ((EICL,volume 12))

Abstract

The range of differential diagnoses for osteolytic lesions in the skeletal system is wide, extending from asymptomatic benign lesions—often diagnosed as incidental findings—to clinically symptomatic high-grade osteosarcomas. In the majority of cases, the lesions are benign and in most cases do not require any therapeutic intervention. Malignant primary bone tumours are a rarity. Due to their inexperience with benign findings, the physicians who initially see the patients (general practitioners, pediatricians, radiologists, orthopaedists, etc.) therefore face a dilemma: on the one hand, they need to carry out extensive diagnostic procedures (including radiological and sometimes also invasive methods) in order to avoid overlooking a possible osteosarcoma. On the other hand, it is by no means rare for patients with an osteosarcoma to be referred to a specialized tumour center only when the lesion is at an extremely advanced stage, as the physicians previously treating the patient did not expect a malignant process.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Hogendoorn PC, ESMO/EUROBONET Working Group, Athanasou N, Bielack S, De Alava E, Dei Tos AP, Ferrari S, Gelderblom H, Grimer R, Hall KS, Hassan B, Hogendoorn PC, Jurgens H, Paulussen M, Rozeman L, Taminiau AH, Whelan J, Vanel D (2010) Bone sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v204–v213

    Article  PubMed  Google Scholar 

  2. Jawad MU, Cheung MC, Min ES, Schneiderbauer MM, Koniaris LG, Scully SP (2009) Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973–2005. Cancer 115:3526–3536

    Article  PubMed  Google Scholar 

  3. Ottaviani G, Jaffe N (2009) The epidemiology of osteosarcoma. Cancer Treat Res 152:3–13

    Article  PubMed  Google Scholar 

  4. Giuffrida AY, Burgueno JE, Koniaris LG, Gutierrez JC, Duncan R, Scully SP (2009) Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am 91:1063–1072

    Article  PubMed  Google Scholar 

  5. Freyschmidt J, Ostertag H, Jundt G (2003) Knochen­tumoren – klinik, radiologie, pathologie, 2nd edn. Springer, Berlin

    Google Scholar 

  6. Dirksen U, Jürgerns H (2009) Ewing-Sarkome und PNET des Kindes- und Jugendalters. Leitlinie der Gesellschaft für Pädiatrische Onkologie und Hämatologie. Arbeitsgemeinschaft der Wissen­schaftlichen Medizinischen Fachgesellschaften online, Register Nr. 025–006

    Google Scholar 

  7. Leithner A, Windhager R (2007) Guidelines for the biopsy of bone and soft tissue tumors. Orthopade 36:167–174

    Article  PubMed  CAS  Google Scholar 

  8. Walden MJ, Murphey MD, Vidal JA (2008) Incidental enchondromas of the knee. AJR Am J Roentgenol 190:1611–1615

    Article  PubMed  Google Scholar 

  9. Pan KL, Chan WH, Chia YY (2010) Initial symptoms and delayed diagnosis of osteosarcoma around the knee joint. J Orthop Surg (Hong Kong) 18:55–57

    Google Scholar 

  10. Widhe B, Widhe T (2000) Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. J Bone Joint Surg Am 82:667–674

    PubMed  CAS  Google Scholar 

  11. Schultheiss M, von Baer A, Gebhard F, Kinzl L, Arand M (2007) Therapy indications and options for skeletal metastasis. Urologe A 46:897–903

    Article  PubMed  CAS  Google Scholar 

  12. Bacci G, Ferrari S, Longhi A, Donati D, Manfrini M, Giacomini S, Briccoli A, Forni C, Galletti S (2003) Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy. Acta Orthop Scand 74:449–454

    Article  PubMed  Google Scholar 

  13. Lee J, Hoang BH, Ziogas A, Zell JA (2010) Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. Cancer 116:1964–1973

    Article  PubMed  Google Scholar 

  14. Lodwick GS, Wilson AJ, Farrell C, Virtama P, Dittrich F (1980) Determining growth rates of focal lesions of bone from radiographs. Radiology 134:577–583

    PubMed  CAS  Google Scholar 

  15. Bielack S (2010) Osteosarkome. Leitlinie der Gesellschaft für Pädiatrische Onkologie und Hämatologie. Arbeitsgemeinschaft der Wissen­schaftlichen Medizinischen Fachgesellschaften online, Register Nr. 025–005

    Google Scholar 

  16. Jacofsky DJ, Haidukewych GJ (2004) Management of pathologic fractures of the proximal femur. State of the art. J Orthop Trauma 18:459–469

    Article  PubMed  Google Scholar 

  17. Andreou D, Bielack SS, Carrle D, Kevric M, Kotz R, Winkelmann W, Jundt G, Werner M, Fehlberg S, Kager L, Kühne T, Lang S, Dominkus M, Exner GU, Hardes J, Hillmann A, Ewerbeck V, Heise U, Reichardt P, Tunn PU (2011) The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. Ann Oncol 22:1228–1235

    Article  PubMed  CAS  Google Scholar 

  18. Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153:106–120

    PubMed  Google Scholar 

  19. Ferguson PC, McLaughlin CE, Griffin AM, Bell RS, Deheshi BM, Wunder JS (2010) Clinical and functional outcomes of patients with a pathologic fracture in high-grade osteosarcoma. J Surg Oncol 102:120–124

    Article  PubMed  Google Scholar 

  20. Peeters SP, Van der Geest IC, de Rooy JW, Veth RP, Schreuder HW (2009) Aneurysmal bone cyst: the role of cryosurgery as local adjuvant treatment. J Surg Oncol 100:719–724

    Article  PubMed  CAS  Google Scholar 

  21. Pietschmann MF, Dietz RA, Utzschneider S, Baur-Melnyk A, Jansson V, Dürr HR (2010) The influence of adjuvants on local recurrence rate in giant cell tumour of the bone. Acta Chir Belg 110:584–589

    PubMed  CAS  Google Scholar 

  22. Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, Hardes J, Gosheger G (2008) Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol 134:969–978

    Article  PubMed  CAS  Google Scholar 

  23. Lindfors NC, Koski I, Heikkilä JT, Mattila K, Aho AJ (2010) A prospective randomized 14-year follow-up study of bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors. J Biomed Mater Res B Appl Biomater 94:157–164

    PubMed  Google Scholar 

  24. Streitbürger A, Ahrens H, Balke M, Buerger H, Winkelmann W, Gosheger G, Hardes J (2009) Grade I chondrosarcoma of bone: the Münster experience. J Cancer Res Clin Oncol 135:543–550

    Article  PubMed  Google Scholar 

  25. Sluga M, Windhager R, Lang S, Heinzl H, Bielack S, Kotz R (1999) Local and systemic control after ablative and limb sparing surgery in patients with osteosarcoma. Clin Orthop Relat Res 358:120–127

    Article  PubMed  Google Scholar 

  26. Gosheger G, Gebert C, Ahrens H, Streitbuerger A, Winkelmann W, Hardes J (2006) Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop 450:164–171

    Article  PubMed  Google Scholar 

  27. Renard AJ, Veth RP, Schreuder HW, van Loon CJ, Koops HS, van Horn JR (2000) Function and complications after ablative and limb-salvage therapy in lower extremity sarcoma of bone. J Surg Oncol 73:198–205

    Article  PubMed  CAS  Google Scholar 

  28. Gebert C, Hillmann A, Schwappach A, Hoffmann C, Hardes J, Kleinheinz J, Gosheger G (2006) Free ­vascularized fibular grafting for reconstruction after tumour resection in the upper extremity. J Surg Oncol 94:114–127

    Article  PubMed  CAS  Google Scholar 

  29. Henderson ER, Groundland JS, Pala E, Dennis JA, Wooten R, Cheong D, Windhager R, Kotz RI, Mercuri M, Funovics PT, Hornicek FJ, Temple HT, Ruggieri P, Letson GD (2011) Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Joint Surg Am 93:418–429

    Article  PubMed  Google Scholar 

  30. Krepler P, Dominkus M, Toma CD, Kotz R (2003) Endoprosthesis management of the extremities of children after resection of primary malignant bone tumors. Orthopade 32:1013–1019

    Article  PubMed  CAS  Google Scholar 

  31. Hardes J, Gebert C, Hillmann A, Winkelmann W, Gosheger G (2003) Rotationplasty in the surgical treatment plan of primary malignant bone tumors. Possibilities and limits. Orthopade 32:965–970

    Article  PubMed  CAS  Google Scholar 

  32. Capanna R, De Biase P, Campanacci DA (2003) A new protocol of surgical treatment of long bone metastases. Ortop Traumatol Rehabil 5:271–275

    PubMed  Google Scholar 

  33. Nathan SS, Healy JH, Mellano D, Hoang B, Lewis I, Morris CD, Athanasian EA, Boland PJ (2005) Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol 23:6072–6082

    Article  PubMed  Google Scholar 

  34. Hardes J, Gosheger G (2008) Die Pathologische Fraktur aus Sicht des Orthopäden/Unfallchirurgen. Trauma und Berufskrankheit 10(Suppl 2):167–174

    Article  Google Scholar 

  35. Cichon CW, Böttner F, Rödl R, Winkelmann W, Lindner N (2006) Minimally invasive treatment of osteoid osteoma with CT-guided radiofrequency ablation in long-term follow-up. Z Orthop Ihre Grenzgeb 144:332–337

    Article  PubMed  CAS  Google Scholar 

  36. Thanos L, Mylona S, Galani D, Tzavoulis D, Kalioras V, Tanteles S, Pomoni M (2008) Radiofrequency ablation of osseous metastases. Skeletal Radiol 37:189–194

    Article  PubMed  CAS  Google Scholar 

  37. Toyota N, Naito A, Kakizawa H, Hieda M, Hirai N, Tachikake T, Kimura T, Fukuda H, Ito K (2005) Radiofrequency ablation therapy combined with cementoplasty for painful bone metastases: initial experience. Cardiovasc Intervent Radiol 28:578–583

    Article  PubMed  Google Scholar 

  38. Rossi G, Mavrogenis AF, Rimondi E, Braccaioli L, Calabrò T, Ruggieri P (2011) Selective embolization with N-butyl cyanoacrylate for metastatic bone disease. J Vasc Interv Radiol 22:462–470

    Article  PubMed  Google Scholar 

  39. De Cristofaro R, Biagini R, Boriani S, Ricci S, Ruggieri P, Rossi G, Fabbri N, Roversi R (1992) Selective arterial embolization in the treatment of aneurysmal bone cyst and angioma of bone. Skeletal Radiol 21:523–527

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jendrik Hardes .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 EFORT

About this chapter

Cite this chapter

Hardes, J. (2012). How to Manage Osteolytic Lesions. In: Bentley, G. (eds) European Instructional Lectures. European Instructional Lectures, vol 12. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27293-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27293-6_5

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-27292-9

  • Online ISBN: 978-3-642-27293-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics